BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Chromosome karyotyping led to the discovery of the first gene alteration in a myeloid neoplasm, the BCR-ABL fusion gene, resulting from t(9;22)-derived Philadelphia chromosome in patients with chronic myelogenous leukemia (CML) [3].